Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
KREBSBIO Stock Analysis
Views
Red Flags
Positive
Not enough talking point with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0678413.
Snapshot
See detailed analysis
KREBSBIO Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
KREBSBIO Bulk, Block & Insider Trades
KREBSBIO Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Rights issue(21 new shares @ 86 INR for 100 existing shares)Rights issue of 2886300 shares. Ex-date: 31st Jan 2019 Announced on: 11th Jan 2019
Company Profile
Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue str... Read More
Key personnel
Dr. R. T. RaviD
Non-Executive Chairman of the Board
Mr. Manish Kumar JainD
Chief Executive Officer, Managing Director, Director
Mr. Ritesh Jain
Chief Financial Officer
Mr. Rakesh Ravindra Kalbate
Compliance Officer, Company Secretary
Mr. Pabitra BhattacharyaD
Managing Director, Additional Director
Mr. Avinash RaviD
Non-Executive Director
Mr. Satya Prakash ChigurupatiD
Additional Independent Director
Mr. Sumanth KarlapudiD
Additional Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Krebs Biochemicals & Industries Ltd.?
The current share price of Krebs Biochemicals & Industries Ltd. is ₹ 66.91 as of 09 Jan 2026.
What is the PE ratio of Krebs Biochemicals & Industries Ltd.?
The Price-to-Earnings (PE) ratio of Krebs Biochemicals & Industries Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Krebs Biochemicals & Industries Ltd.?
Krebs Biochemicals & Industries Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of -31.60% as per the latest financial reports.
What is the market cap of Krebs Biochemicals & Industries Ltd.?
The market capitalization of Krebs Biochemicals & Industries Ltd. stands at ₹ 144.26 Cr.
What is the dividend yield of Krebs Biochemicals & Industries Ltd.?
The dividend yield of Krebs Biochemicals & Industries Ltd. is 0.00% based on the current market price.
What is the RSI of Krebs Biochemicals & Industries Ltd.?
The Relative Strength Index (RSI) of Krebs Biochemicals & Industries Ltd. is 42.95.
What is the FII and DII holding in Krebs Biochemicals & Industries Ltd.?
Foreign Institutional Investors (FII) hold 0.49% and Domestic Institutional Investors (DII) hold 0.00% of Krebs Biochemicals & Industries Ltd. shares.
What sector does Krebs Biochemicals & Industries Ltd. belong to?
Krebs Biochemicals & Industries Ltd. operates in the Healthcare sector.
What is the beta of Krebs Biochemicals & Industries Ltd. stock?
The beta of Krebs Biochemicals & Industries Ltd. stock is 1.19, indicating its volatility relative to the broader market.
